POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

NCT04193956 · clinicaltrials.gov ↗

RECRUITING

Status

3500

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Non-Small Cell Lung Cancer

Interventions

OTHER: Standard-of-care procedures
OTHER: Study procedures

Sponsor

University Medical Center Groningen